Literature DB >> 29668921

Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn's Disease.

Parakkal Deepak1, Joel G Fletcher2, Jeff L Fidler2, John M Barlow2, Shannon P Sheedy2, Amy B Kolbe2, William S Harmsen3, Terry Therneau3, Stephanie L Hansel1, Brenda D Becker1, Edward V Loftus1, David H Bruining1.   

Abstract

Background: The long-term significance of radiological transmural response (TR) as a treatment goal at the first follow-up scan in small bowel Crohn's disease (CD) has been previously shown. We examined the durability of a long-term strategy of treating to a target of radiological TR and the influence of baseline predictors on the maintenance of TR.
Methods: Small bowel CD patients between January 1, 2002, and December 31, 2014, were identified with serial computed tomography enterography (CTE)/magnetic resonance enterography (MRE) before and after initiation of therapy or on maintenance therapy. Overall TR (inflammatory lesions with/without strictures) w1as characterized by abdominal radiologists in up to 5 small bowel lesions per patient at each serial scan until last follow-up or small bowel resection, as response, partial response, or nonresponse. The rate of conversion between TR states and transition to surgery, including the effect of baseline patient/disease characteristics, was examined using a multistate model (mstate R-package).
Results: CD patients (n = 150, 705 CTE/MRE) with a median of 4 CTE/MRE during 4.6 years of follow-up, 49% with ileal-only distribution, had 260 examined bowel segments. Conversion from response to partial response/nonresponse was 37.4% per year of follow-up with no transitions seen directly from response to surgery. Current smoking status (hazard ratio [HR], 2.2; 95% confidence interval [CI], 1.1-4.3) and internal penetrating disease at baseline scan (HR, 2.2; 95% CI, 1.2-4.1) were associated with a 2-fold increased risk of transition from partial response/nonresponse to surgery. Conclusions: Achievement and maintenance of radiological response is associated with avoidance of small bowel surgery. Continued follow-up with CTE/MRE is recommended to identify loss of response, especially in current smokers and patients with internal penetrating disease at baseline CTE/MRE.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29668921      PMCID: PMC6391864          DOI: 10.1093/ibd/izy074

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  37 in total

1.  Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy.

Authors:  Sunil Samuel; David H Bruining; Edward V Loftus; Brenda Becker; Joel G Fletcher; Jayawant N Mandrekar; Alan R Zinsmeister; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

2.  Tutorial in biostatistics: competing risks and multi-state models.

Authors:  H Putter; M Fiocco; R B Geskus
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

Review 3.  Inflammatory bowel disease (1)

Authors:  D K Podolsky
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

4.  EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.

Authors:  William A Faubion; Joel G Fletcher; Sharon O'Byrne; Brian G Feagan; Willem Js de Villiers; Bruce Salzberg; Scott Plevy; Deborah D Proctor; John F Valentine; Peter D Higgins; Jeffrey M Harris; Lauri Diehl; Lilyan Wright; Gaik Wei Tew; Diana Luca; Karen Basu; Mary E Keir
Journal:  Am J Gastroenterol       Date:  2013-10-15       Impact factor: 10.864

5.  Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.

Authors:  Paul Rutgeerts; Robert H Diamond; Mohan Bala; Allan Olson; Gary R Lichtenstein; Weihang Bao; Kamlesh Patel; Douglas C Wolf; Michael Safdi; Jean Frederic Colombel; Bret Lashner; Stephen B Hanauer
Journal:  Gastrointest Endosc       Date:  2006-03       Impact factor: 9.427

6.  Adalimumab induces deep remission in patients with Crohn's disease.

Authors:  Jean-Frédéric Colombel; Paul J Rutgeerts; William J Sandborn; Mei Yang; Anne Camez; Paul F Pollack; Roopal B Thakkar; Anne M Robinson; Naijun Chen; Parvez M Mulani; Jingdong Chao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-12       Impact factor: 11.382

7.  Endoscopic Skipping of the Terminal Ileum in Pediatric Crohn Disease.

Authors:  Ishrat Mansuri; Joel G Fletcher; David H Bruining; Amy B Kolbe; Jeff L Fidler; Sunil Samuel; Jeanne Tung
Journal:  AJR Am J Roentgenol       Date:  2017-04-05       Impact factor: 3.959

8.  Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Authors:  C Cellier; T Sahmoud; E Froguel; A Adenis; J Belaiche; J F Bretagne; C Florent; M Bouvry; J Y Mary; R Modigliani
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

9.  Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques.

Authors:  Seung Soo Lee; Ah Young Kim; Suk-Kyun Yang; Jun-Won Chung; So Yeon Kim; Seong Ho Park; Hyun Kwon Ha
Journal:  Radiology       Date:  2009-03-10       Impact factor: 11.105

Review 10.  The natural history of adult Crohn's disease in population-based cohorts.

Authors:  Laurent Peyrin-Biroulet; Edward V Loftus; Jean-Frederic Colombel; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2009-10-27       Impact factor: 10.864

View more
  5 in total

1.  Crohn's disease active inflammation assessment with iodine density from dual-energy CT enterography: comparison with endoscopy and conventional interpretation.

Authors:  Bari Dane; Amelia Kernizan; Thomas O'Donnell; Robert Petrocelli; Wendy Rabbenou; Sumona Bhattacharya; Shannon Chang; Alec Megibow
Journal:  Abdom Radiol (NY)       Date:  2022-07-14

2.  Correlation between imaging findings on outpatient MR enterography (MRE) in adult patients with Crohn disease and progression to surgery within 5 years.

Authors:  Bari Dane; Kun Qian; Rachel Krieger; Paul Smereka; Jonathan Foster; Chenchan Huang; Shannon Chang; Sooah Kim
Journal:  Abdom Radiol (NY)       Date:  2022-08-02

3.  Assessing Small Bowel Stricturing and Morphology in Crohn's Disease Using Semi-automated Image Analysis.

Authors:  Ryan W Stidham; Binu Enchakalody; Akbar K Waljee; Peter D R Higgins; Stewart C Wang; Grace L Su; Ashish P Wasnik; Mahmoud Al-Hawary
Journal:  Inflamm Bowel Dis       Date:  2020-04-11       Impact factor: 5.325

4.  Using MR Enterography and CT Enterography for Routine Crohn's Surveillance: How We Do It Now, and How We Hope to Do it in the Future.

Authors:  Lukasz Kwapisz; David H Bruining; Joel G Fletcher
Journal:  Korean J Radiol       Date:  2022-01       Impact factor: 3.500

5.  Inter-reader agreement of the Society of Abdominal Radiology-American Gastroenterological Association (SAR-AGA) consensus reporting for key phenotypes at MR enterography in adults with Crohn disease: impact of radiologist experience.

Authors:  Bari Dane; Kun Qian; Simon Gauvin; Hoon Ji; Jay Karajgikar; Nancy Kim; Shannon Chang; Hersh Chandarana; Sooah Kim
Journal:  Abdom Radiol (NY)       Date:  2021-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.